UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000036295
Receipt number R000041294
Scientific Title Phase 1 Dose Escalation Study of Bosutinib in Patients with Amyotrophic Lateral Sclerosis (ALS)
Date of disclosure of the study information 2019/03/26
Last modified on 2021/09/22 22:33:22

No. Disposal Last modified on Item of update
1 Insert 2019/03/26 13:59:53
2 Update 2019/04/23 11:55:26 Institutions
3 Update 2019/04/23 12:50:37 Institutions
4 Update 2019/06/11 16:42:17 Key exclusion criteria
Key exclusion criteria
5 Update 2020/03/24 15:07:24 Key exclusion criteria
6 Update 2020/03/24 15:09:03 Address
Address
7 Update 2020/03/24 15:15:47 Key exclusion criteria
8 Update 2020/09/24 09:19:26 Last follow-up date
9 Update 2021/01/26 14:02:04 Division name
10 Update 2021/01/26 14:03:41 Last follow-up date
11 Update 2021/03/26 09:16:19 Recruitment status
12 Update 2021/04/20 09:46:58 Recruitment status
Last follow-up date
13 Update 2021/07/05 08:57:43 Email
14 Update 2021/09/22 22:29:10 Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Adverse events
Adverse events
Plan to share IPD
Plan to share IPD
IPD sharing Plan description
IPD sharing Plan description
15 Update 2021/09/22 22:32:12 Date of closure to data entry
16 Update 2021/09/22 22:33:22 Recruitment status